Lynx1 Capital Management
Lynx1 Capital Management is a Puerto Rico-based hedge fund manager founded in 2020 that primarily invests in U.S. biotechnology and life science companies. The firm uses a long-bias equity strategy and has disclosed holdings in companies like Merus N.V. and GH Research PLC.
Weston Nichols is the founder and Managing Partner of Lynx1 Capital, a biotechnology-focused investment fund founded in March 2020. He has a strong background in life sciences investing, having worked as an analyst at Perceptive Advisors from 2016 to 2020, and prior roles at Balyasny Asset Management and SunTrust Robinson Humphrey in biotechnology equity research. He holds a B.S. in Biological Engineering from Cornell University and a Ph.D. in Neuroscience from the California Institute of Technology. Nichols also serves on the board of directors at Crinetics Pharmaceuticals, reflecting his expertise in the biotech and life sciences sector. Lynx1 Capital manages assets focused on biotechnology and medical technology companies, with a long-term investment approach and a strong scientific foundation
Nil
Companies with fund stakes involved in activist actions such as 13D filing(s) or proxy campaign(s).
Subscribe to continue reading